Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer is relatively rare and often challenging to treat. Traditional treatments, like surgery, targeted therapy, and immunotherapy, have improved the outlook for many patients. Recently, Traditional Chinese Herbal Medicine (TCHM) has been explored as a complementary treatment option, with promising results for ccRCC. One such treatment is the herbal formula Bu-Shen-Jian-Pi-Fang (BSJPF), which contains several herbs known for their anti-cancer properties.
Your purchase includes a 30 minute consultation for integration, modification and instruction.
What is Clear Cell Renal Cell Carcinoma?
ccRCC arises from the cells lining the proximal convoluted tubules in the kidneys. It is characterized by the presence of clear cytoplasm in the tumor cells when observed under a microscope. This form of kidney cancer often presents with symptoms like blood in urine (hematuria), pain in the side, a mass or lump in the abdomen, and unexplained weight loss. Metastasis is common, and about one-third of ccRCC patients have metastatic disease at the time of diagnosis.
What is the Clear Cell Renal Cell Carcinoma Treatment with Traditional Chinese Herbal Medicine (TCM) treatment Bu-Shen-Jian-Pi-Fang (BSJPF)?
BSJPF is a long-standing formulation in Traditional Chinese Herbal Medicine and has been extensively research for treatment of Clear Cell Renal Cell Carcinoma. BSJPF is made up of various herbs, each contributing unique benefits:
Angelica promotes blood circulation and inhibits cancer cell growth.
Salvia has anti-inflammatory and antioxidant effects.
Poria offers diuretic and anti-tumor properties.
Wolfberry strengthens the immune system with its high antioxidant content.
Pueraria Root helps reduce inflammation and affects cancer cell metabolism.
Coptis chinensis contains compounds that slow tumor cell growth.
How Does Bu-Shen-Jian-Pi-Fang Work Against ccRCC? Research suggests that BSJPF targets several pathways involved in cancer development:
Glycolysis Regulation: It enhances the metabolism of glucose, which is crucial for tumor survival.
HIF-1 Pathway: BSJPF may influence a pathway that helps tumors adapt to low oxygen, a common feature in ccRCC.
Immune System Modulation: BSJPF boosts immune system activity, making the tumor more vulnerable to the body’s defenses.
Preclinical Evidence.
In animal studies, BSJPF reduced tumor size and increased immune system activity, showing its potential to enhance the effects of conventional therapies like immunotherapy. https://pmc.ncbi.nlm.nih.gov/articles/PMC8202066/
Scutellaria Baicalensis and Kidney Cancer
Another herbal treatment, Scutellaria baicalensis, has also shown promise for treating renal cell carcinoma. It has 36 active compounds, such as wogonin, interact with key cancer-related proteins, blocking tumor growth and encouraging cell death. Studies suggest that this herb works through multiple pathways, making it a promising addition to cancer treatment. https://pubmed.ncbi.nlm.nih.gov/38095405/
Genistein’s Role in Kidney Cancer
Genistein, found in soybeans, and is a multifaceted compound with the potential to protect and treat various kidney diseases, including cancer, through its anti-inflammatory, antioxidant, and cell-protective properties. Genistein inhibits the proliferation and migration of kidney cancer cells, induces apoptosis, and suppresses angiogenesis, making it a promising adjunct in kidney cancer treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC9506319/
Conclusion
BSJPF, Scutellaria baicalensis, and genistein are all emerging treatments for ccRCC. While promising, these therapies should complement traditional methods like surgery and immunotherapy. Further research is needed to fully understand their effectiveness and potential in treating kidney cancer. But in the meantime Clear Cell Renal Cell Carcinoma treatment with TCM Bu Shen Jian Pi Fang appears to be a valuable tool against this disease.
Additional Information about Clear Cell Renal Cell Carcinoma
Diagnosis of Clear Cell Renal Cell Carcinoma
The diagnosis of ccRCC often involves:
Imaging Tests: CT scans, MRI, and ultrasound to detect the tumor's size, location, and any spread to nearby organs or lymph nodes.
Biopsy: A needle biopsy may be done to confirm the presence of cancer cells.
Blood Tests: Elevated calcium levels, liver enzymes, and kidney function markers may indicate the presence of ccRCC.
Treatment Options for ccRCC
The treatment for ccRCC depends on the stage of the disease and the general health of the patient. Current treatment strategies are mainly focused on surgery, targeted therapies, and immunotherapy.
1. Surgical Treatment
Radical Nephrectomy: The removal of the entire kidney is the primary treatment for localized ccRCC.
Partial Nephrectomy: In cases where the tumor is smaller or located in an area that allows for preservation of kidney function, partial nephrectomy is considered.
2. Targeted Therapy
Targeted therapies are used for advanced or metastatic ccRCC, focusing on specific pathways involved in tumor growth.
Tyrosine Kinase Inhibitors (TKIs): Drugs like sunitinib and pazopanib target the vascular endothelial growth factor (VEGF) receptor, inhibiting blood vessel growth in tumors.
mTOR Inhibitors: These include drugs like everolimus and temsirolimus, which inhibit cell growth and division by targeting the mTOR pathway.
3. Immunotherapy
Immunotherapy aims to enhance the body's immune system to fight cancer. Common immunotherapy drugs used in ccRCC include:
Checkpoint Inhibitors: Drugs such as nivolumab and pembrolizumab block PD-1 receptors, allowing immune cells to attack the tumor.
Cytokine Therapy: Interleukin-2 (IL-2) and interferon-alpha are used to boost immune responses.
4. Radiation Therapy
Radiation is typically used for palliative care in cases where the cancer has spread to other parts of the body, such as bones or the brain.
5. Chemotherapy
Chemotherapy is less effective for ccRCC and is not commonly used, except for cases where other treatments fail.
Mortality and Survival Rates
The prognosis for ccRCC varies depending on the stage at diagnosis and the effectiveness of treatment:
Localized ccRCC: The 5-year survival rate for patients with localized disease is approximately 90-95%.
Metastatic ccRCC: For patients with metastatic disease, the survival rate drops significantly. The median survival for these patients is less than 12 months, with some individuals living longer if they respond well to treatments such as immunotherapy and targeted therapies.
Recent advancements in immunotherapy have improved the outlook for metastatic ccRCC, and long-term survival is becoming more achievable for some patients.
Recovery and Quality of Life
Recovery from ccRCC varies greatly depending on the stage and treatment method. Patients who undergo successful surgery and early-stage treatment may return to normal activities within a few months. For advanced stages, treatment focuses on prolonging life and managing symptoms to maintain quality of life.
Side Effects of Treatment
Tyrosine Kinase Inhibitors: Side effects may include fatigue, hypertension, diarrhea, and skin issues.
Immunotherapy: While generally well-tolerated, it can lead to immune-related side effects such as inflammation of organs.
Surgery: Risks include infection, bleeding, and kidney function loss.
Conclusion
Clear cell renal cell carcinoma is a challenging diagnosis, but with early detection, surgery, and emerging treatments such as targeted therapy and immunotherapy, the prognosis has improved for many patients. The introduction of Traditional Chinese Herbal Medicine, particularly the formula Bu-Shen-Jian-Pi-Fang (BSJPF), offers an innovative and potentially complementary treatment option. As research continues to explore its mechanisms and effectiveness, BSJPF could play a crucial role in enhancing the treatment of ccRCC, especially when integrated with modern therapies for a holistic approach to cancer care.
Comments